Suzanne Messere | Investor Relations, Stern |
Stephen Willard | Chief Executive Officer and Director |
Seth Van Voorhees | Chief Financial Officer |
Jonathan C. Javitt | Chief Scientist and Director |
Edward Woo | Ascendiant Capital Markets LLC |
Jason Kolbert | Dawson James Securities |
Good day, everyone, and welcome to NRx Pharmaceuticals’ First Quarter 2023 Earnings Conference Call. All participants will be in a listen-only mode. [Operator Instructions]. After today's presentation, there will be an opportunity to ask questions. [Operator Instructions].